BTAI
Bioxcel Therapeutics
$2.85
Earnings Summary
Revenue | $0.38Mn |
Net Profits | $-22.26Mn |
Net Profit Margins | -5919.15% |
Highlights
Bioxcel Therapeutics’s revenue jumped 57.98% since last year same period to $0.38Mn in the Q4 2023. On a quarterly growth basis, Bioxcel Therapeutics has generated 10.26% jump in its revenue since last 3-months.
Bioxcel Therapeutics’s net profit jumped 61.68% since last year same period to $-22.26Mn in the Q4 2023. On a quarterly growth basis, Bioxcel Therapeutics has generated 55.92% jump in its net profits since last 3-months.
Bioxcel Therapeutics’s net profit margin jumped 75.75% since last year same period to -5919.15% in the Q4 2023. On a quarterly growth basis, Bioxcel Therapeutics has generated 60.02% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Bioxcel Therapeutics post its latest quarter earnings
EPS Estimate Current Quarter | -0.73 |
EPS Estimate Current Year | -0.73 |
Highlights
Bioxcel Therapeutics’s earning per share (EPS) estimates for the current quarter stand at -0.73 - a 19.78% jump from last quarter’s estimates.
Bioxcel Therapeutics’s earning per share (EPS) estimates for the current year stand at -0.73.
Key Ratios
Key ratios of the Bioxcel Therapeutics post its Q4 2023 earnings
Earning Per Share (EPS) | -0.76 |
Highlights
Bioxcel Therapeutics’s earning per share (EPS) jumped 61.03% since last year same period to -0.76 in the Q4 2023. This indicates that the Bioxcel Therapeutics has generated 61.03% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-03-22 | -0.91 | -0.76 | 16.48% |
2023-09-30 | -1.3 | -1.72 | -32.31% |
2023-08-14 | -1.75 | -1.83 | -4.57% |
2023-05-09 | -1.62 | -1.84 | -13.58% |
₹0 US Stocks a/c Opening Fee